Globe Capital Market is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 410 in its research report dated Jun 01, 2020.
HDFC Securities is bullish on Glenmark has recommended buy rating on the stock with a target price of Rs 500 in its research report dated August 16, 2019.
ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 410 in its research report dated August 14, 2019.
ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 565 in its research report dated May 30, 2019.
Sharekhan recommended Hold rating on Glenmark Pharmaceuticals with a target price of Rs 595 in its research report dated May 30, 2019.
HDFC Securities is bullish on Glenmark has recommended buy rating on the stock with a target price of Rs 790 in its research report dated November 15, 2018.
HDFC Securities is bullish on Glenmark has recommended buy rating on the stock with a target price of Rs 691 in its research report dated August 16, 2018.
HDFC Securities is bullish on Glenmark has recommended buy rating on the stock with a target price of Rs 710 in its research report dated May 31, 2018.
Prabhudas Lilladher recommended accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 733 in its research report dated November 03, 2017.
Sharekhan recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 730 in its research report dated November 03, 2017.
ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 670 in its research report dated November 03, 2017.
Edelweiss recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 670 in its research report dated November 03, 2017.
Axis Direct is bullish on Glenmark has recommended buy rating on the stock with a target price of Rs 840 in its research report dated August 02, 2017.
IDBI Capital is bullish on Glenmark Pharmaceuticals has recommended Hold rating on the stock with a target price of Rs 763 in its research report dated July 28, 2017.
Reliance Securities is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 900 in its research report dated July 31, 2017.
ICICI Direct has recommended Hold rating on Glenmark Pharmaceuticals with a target price of Rs 730 in its research report dated July 31, 2017.
HDFC Securities is bullish on Glenmark Pharmaceuticals has recommended Buy rating on the stock with a target price of Rs 1035 in its research report dated July 28, 2017.
Edelweiss is bullish on Glenmark Pharmaceuticals has recommended Hold rating on the stock with a target price of Rs 670 in its research report dated July 28, 2017
Geojit Research recommended Buy rating on Glenmark Pharma with a target price of Rs 774 in its research report dated July 05, 2017.
Axis Direct is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 900 in its research report dated May 18, 2017.
HDFC Securities is bullish on Glenmark has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated May 13, 2017.
ICICI Direct is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 910 in its research report dated May 15, 2017.
Systematix has recommended accumulate rating on Glenmark Pharma with a target price of Rs 875 in its research report dated May 12, 2017.
Axis Direct is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated March 24, 2017.
In an interview to CNBC-TV18 SP Tulsian, sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.